Thinking about treatment options in advanced cancer; prognostication; shared decision making
MBBS MMed (ClinEpi) FRACP
Dr Shalini Subramaniam is a Medical Oncologist with an interest in genitourinary, lung and breast cancers.
She was awarded MBBS from the University of New South Wales in 2011 and a Master of Medicine (Clinical Epidemiology) in 2021. After completing her oncology training at St. Vincent’s and Campbelltown Hospitals in Sydney, she joined the CTC in 2019 as a Research Fellow for the Australian and New Zealand Urogenital and Prostate Cancer (ANZUP) Trials Group and Thoracic Oncology Group of Australasia (TOGA).
Shalini is currently undertaking a PhD at the CTC with support of an NHMRC Postgraduate Research Scholarship. Patients with advanced cancers often misunderstand the aims and benefits of palliative anticancer therapy. Her research aims to enhance patient understanding of the effects of their treatment, with a focus on developing a communication aid to help oncologists better explain survival benefits of different treatment options.